We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, blood glucose meters, rapid t... read more Featured Products: More products

Download Mobile App





77 Elektronika Showcases Latest Developments in Urinalysis

By LabMedica International staff writers
Posted on 08 Feb 2024
Print article
Image: The new pediatric measurement mode of LabUMat 2 and UriSed 3 PRO demonstrated at Medlab Middle East 2024 (Photo courtesy of 77 Elektronika)
Image: The new pediatric measurement mode of LabUMat 2 and UriSed 3 PRO demonstrated at Medlab Middle East 2024 (Photo courtesy of 77 Elektronika)

At Medlab Middle East 2024, 77 Elektronika (Budapest, Hungary) is demonstrating how its high-end urinalysis products can boost laboratory efficiency.

77 Elektronika is showcasing its full product range, including its latest developments in urinalysis, such as the new pediatric measurement mode of LabUMat 2 and UriSed 3 PRO or the brand new research use only (RUO) feature of the UriSed mini device. Urine sediment analysis is very sensitive to inhomogeneous particle distribution in the sample: some urine sediment particles subside quickly and hence, proper mixing is crucial to obtain reliable results. 77 Elektronika has implemented sample level adaptive mixing procedure into its fully automated UriSed technology instruments, the UriSed 2 and UriSed 3 PRO. During sample mixing some urine is aspirated from the test tube and pushed back again. This “sip and spit” mixing is repeated to make sure that all particles are homogenized. This standardized method provides consistent results quickly and effectively.

Visitors to the 77 Elektronika booth at Medlab Middle East 2024 can experience UriSed Technology which offers a premium category solution for sediment analysis, providing high-resolution whole-view field microscopic images in an automatic and reproducible way. The goal of UriSed Technology is to make urinary sediment analysis faster, more reliable, and more operator-independent, eliminating the need for manual microscopy while adhering to gold standard guidelines. With UriSed technology, laboratories can achieve accurate and dependable results in just a fraction of the time it takes with traditional methods. The technology provides a detailed analysis of urine samples, detecting red and white blood cells, epithelial cells, bacteria, and other microscopic elements. This makes it an essential tool for diagnosing various medical conditions, including urinary tract infections, kidney diseases, and many more. The fully automated UriSed 3 PRO urine sediment analyzer provides automatic and reproducible results, ensuring that each sample is analyzed with the same precision and accuracy. Also on display at the event is the UriSed mini device which now comes with the brand new feature of Body Fluid Measurement mode which is available only for RUO mode and not for diagnostic purposes. The two measurement phases of stained and unstained samples enable a wider range of sample analysis that includes various body fluid types.

Related Links:
77 Elektronika

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Auto 5-Part Differential Analyzer
XR-1000 Pure
New
Urine Analyzer
URIT-180

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.